NYSE:BTX
Delisted
BioTime, Inc Stock Company Profile
$0.93
+0.0118 (+1.28%)
At Close: Sep 24, 2020
Information
10355 Science Center Drive, Suite 150
San Diego CA 92121
212 582 1199
www.brooklynitx.com
Industry: Biotechnology
Sector: Healthcare
Description
Brooklyn ImmunoTherapeutics, Inc., a clinical stage biopharmaceutical company, engages in developing therapies to treat patients with cancer. Its advanced program is IRX-2 that is in a Phase 2b clinical trial in patients with squamous cell cancer of the head and neck. The company also develops therapies using gene-editing and cell therapy technology for the treatment of oncology, blood disorder, and monogenic disease. Brooklyn ImmunoTherapeutics, Inc. is based in Brooklyn, New York.